Cost-effectiveness of denosumab as a bone protective agent for patients with castration resistant prostate cancer.
about
Cost-effectiveness of denosumab as a bone protective agent for patients with castration resistant prostate cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cost-effectiveness of denosuma ...... ion resistant prostate cancer.
@en
type
label
Cost-effectiveness of denosuma ...... ion resistant prostate cancer.
@en
prefLabel
Cost-effectiveness of denosuma ...... ion resistant prostate cancer.
@en
P2860
P1476
Cost-effectiveness of denosuma ...... ion resistant prostate cancer.
@en
P2093
Athanasios Dellis
Athanasios Papatsoris
P2860
P356
10.1586/14737167.2016.1123624
P577
2015-11-20T00:00:00Z